Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

Similar documents
The Centre for Disease Prevention and Control, Latvia

Central Manchester University Hospitals NHS Foundation Trust, UK

National Center for Tumor Diseases (NCT) Heidelberg, Germany

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Hospital Carlos Haya. Malaga, Spain

INSTITUTE OF CHILD HEALTH, Greece

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

Department of Medical Genetics, Medical School, University of Athens, Greece

Ministry for Health, the Elderly and Community Care, Malta

European Society of Cardiology, France

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

Cystic Fibrosis Europe (CFE), Germany

Schoen Kliniken group, Schoen Klinik Hamburg Eilbek, Dept. of neurology and. neurorehabilitation, Germany

VSOP, Lupus Netherlands

European Haemophilia Consortium

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

ERN board of Member States

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

European Quality Assurance Scheme for Breast Cancer Services

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

European Reference Networks: strategic value for the Member States. Perspective of France

National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

ERN Assessment Manual for Applicants

3rd Health Programme

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

Revised forms for the submission of the Confidence-Building Measures

European Reference Networks (ERN) Guide for patient advocates

A short paper for ENVI & IMCO MEPs Two solutions to improve recognition of specialisms in the Chapter III professions

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

Spreading Excellence and Widening Participation in Horizon 2020

Developing a European Registry for Rare Anaemias

Regulation of the Cabinet of Ministers regulating implementation of the measure of specific support objective

Current trends in European microbiology

Legal and financial issues Evaluation process

Brokerage for the first ProSafe Call Dina Carrilho Call Secretariat Foundation for Science and Technology (FCT), Portugal

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

FP7: Marie Curie Actions

EFLM EUROPEAN FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Spreading Excellence and Widening Participation in Horizon 2020 TWINNING

European network of paediatric research (EnprEMA)

Level 4 Award in Health Emergency Preparedness, Resilience and Response

Delegations will find below the above-mentioned Council conclusions, as endorsed by the Council (General Affairs) on 14 September 2015.

Emergency contingency planning at designated Points of Entry

The European network evaluation of the PHAR QA framework of competences for...

The Seventh Framework Programme for candidate and potential candidate countries European Regional Economic Forum Nova Gorica, 30 May 2007

CaixaImpulse Form 2017

ERC Grant Schemes. Horizon 2020 European Union funding for Research & Innovation

Mandatory accreditation of Medical labs in France: Benchmark for the EU countries? Michel Vaubourdolle

Building the Europe of Knowledge

Guideline for Applicants. Intramural Research Funding Programs Faculty of Medicine Tübingen

Introduction to ibmg. Marco Varkevisser Director of Education

BCoDE Burden of Communicable Diseases in Europe Improving the usability and communication of burden of disease methods and outputs: the BCoDE toolkit

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

Call for Nominations. CARLOS V European Award

EFSA: mission and tasks, strategic perspectives and cooperation activities

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

The clinical scientist in pathology. March 2005

Do terms like FP6, CORDIS, Specific Programme, Call for

Supportive Care Roundtable

Contribution of DG SANTE to disaster management veterinary perspective

JOB DESCRIPTION 1 Job Title 2 Location 3 Record Filename. Medical Scientist Haematology Laboratory MF-HAE-JD-03

ANNEX I TO VIII ANNEX I. Health Programme Work Programme for 2017

European Funding Opportunities in the field of Language Teaching and Learning

Health and Social Care

Healthcare Science Assistant

European Investment Advisory Hub

Presenting the European Investment Advisory Hub Annual Forum of the EUSDR, 2015 Ulm. European Investment Advisory Hub 1

Support for Risk Assessment Funding Opportunities in Germany

116 Help Lines for Rare Diseases

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

Joint Conference Tempus/Erasmus Mundus University of Stuttgart 8 10 November 2011

Summary of a Survey on the Europe 2020 Flagship Initiative Innovation Union. Executive Summary

Changes in the Medical Device Legislation; the day after. Jan Bart Hak 1

The Enterprise Europe Network Opportunities for International Technology Transfer in the Water Sector. Peter Wolfmeyer ZENIT GmbH

H2020 Work Programme : Spreading Excellence and Widening Participation Call: H2020-TWINN-2015: Twinning Frequently Asked Questions (FAQ)

Partner in care solutions

Potential challenges when assessing organisational processes for assurance of clinical competence in labs with limited clinical staff resource

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

Erasmus+ Programme Jean Monnet Activities. Snejina Nikolova Education, Audiovisual and Culture Executive Agency (EACEA)

Clinical Microbiology and Infectious Diseases Working together. An ESCMID perspective.

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals

ERC funding opportunities

The following passage wants to illustrate the insufficiencies in CF care the patients, their families and care giver struggle with:

Simona Bovha, CPCM European Investment Bank. European Investment Advisory Hub

JOINT DECLARATION ON THE PROMOTION AND THE ENFORCEMENT OF CANCER PATIENTS RIGHTS

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

The ERC funding strategy

Delegations will find attached document EEAS 02246/8/14 REV 8.

Measuring Digital Maturity. John Rayner Regional Director 8 th June 2016 Amsterdam

Document: Report on the work of the High Level Group in 2006

A European workforce for call centre services. Construction industry recruits abroad

Current and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary

Council, 25 September 2014

The Riga Roadmap Investing in Health and Wellbeing for All

Transcription:

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Academic/public health and healthcare specialised institution/organisation (e.g. Institutes and University Departments of Public Health, Quality, Healthcare, Clinical Excellence) Please indicate level: National level organisation Please indicate for what the administration is responsible: 1.1.1. Other (please specify): 1.2 Please indicate the name of your organisation or centre: Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC) 1.3 Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: LV 1. Please indicate the number of EU Member States and EEA countries (rway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1 1.5 If need be, can we contact you by e-mail to obtain further information on your submission? 1.5.1 Please provide an e-mail address where we can contact you: Baiba.rozentale@aslimnica.lv; lic@aslimnica.lv Yes

1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): Baiba Rozentale Chief Medical of Riga East university hospital Stacionary Infectology Center of Latvia Linezera Street 3, LV- 1006 Riga, Latvia Tel. +371 6701500 Fax: +371 6701568 Baiba.rozentale@aslimnica.lv 1.7 Please provide additional contact details if needed: 2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC). 2.1 How would you describe your organisation's knowledge of CoE and HSHC? 2.1.1 Space for further comments: GISRS,GPLN,EISN,EDSN,EC CBRN ADVISORY GROUP,ENIVD- CLRN,EUpert LabNet,ELDSNet,WHO Measles/Rubella lab network, EUVAC.Net,FWD-Net,HAI-Net,EBSA,QUANDHIP,IBD labnet,european Network for STI Surveillance High 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) Professional performance, clinical practice, quality and safety of specialized healthcare 2.2.1. Space for further comments: Provide reference diagnostics;ref. materials supply;scientific advice;participate in research programs; monitoring alerts,2/7 preparedness and response.work according to ISO15189 and ISO17025 2.3 Is highly specialised healthcare a priority in your organisation's strategies and work plans? 2.3.1 Space for further comments: comments High

2.. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Laboratories and central services (e.g. pathology, genetics, biochemistry, pharmacy, microbiology etc.) Please specify: 2.5. Has your organisation/centre been directly involved in the design or assessment of professional standards and criteria related with highly specialised healthcare? Bacteriology,Immunochem,Molecular biology,virology Frequently 2.5.1 Please describe your role in such actions/projects: Provide with informative methodical support for infectious disease laboratory diagnostic;supply with ref. material resources;offering scientific advice;participating in research programs and networks 2.6. Has your organisation been involved in projects/activities supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare? 2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? 2.7.1 Space for further comments: comments 2.13. What is the scope of the network? 2.1. Which kind of network? 2.1.1 Space for further comments:

2.15. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, 5 = very interested) 2.15.1 Space for further comments: 3. Proposed criteria for ERN (scope, general and specific criteria) 3.1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN 3.1.1. Need of highly specialised healthcare 5 3.1.1.1. Complexity of the diagnosis and treatment 3.1.1.2. High cost of treatment and resources 3 3.1.1.3. Need of advanced/highly specialised medical equipment or infrastructures 3.1.2. Need of particular concentration of expertise and resources 5 3.1.2.1. Rare expertise/need of concentration of cases 3.1.2.2. Low prevalence/incidence/number of cases 3.1.2.3. Evaluated experiences of Member States 3.1.3. Based on high-quality, accessible and cost-effective healthcare 3.1.3.1. Evidence of the safety and favourable risk-benefit analysis

3.1.3.2. Feasibility and evidence of the value and potential positive outcome (clinical) 3.1.. Do you recommend any additional criteria or option that would effectively address the issue? 3.1.5. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria? Yes 3.1.5.1 Explain your proposal in free text: RG3 agents;bacterial enter m/o;c.diphtheriae; Staph.- Streptococci; Meningococci;VHA,B,C,D,E;HIV;Influenza;Polio and other Enteroviruses;Measles,Rubella,Mump;TBE, Borrelia;Herpes;viral gastroenteritis 3.2. General criteria of the centres wishing to join a European Reference Network 3.2.1. Organisation and management 3.2.2. Patients empowerment and centered care 3.2.3. Patient care, clinical tools and health technology assessment 3.2.. Quality, patient safety and evaluation framework policies 3.2.5. Business continuity, contingency planning and response capacity 3.2.6. Information systems, technology and e-health tools and applications 3.2.7. Overall framework and capacity for research and training

3.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 3.2.9. Do you recommend any additional option that would effectively address the issue? 3.2.9.1. Space for further comments: comments 3.3. Specific criteria regarding the areas of expertise 3.3.1. Competence, experience and good outcomes and care 5 3.3.2. Specific resources and organisation: 5 3.3.2.1. Human resources 5 3.3.2.2. Team/centre organisation 5 3.3.2.3. Structural conditions 3.3.2.. Specific equipment 3.3.2.5. Presence and coordination with other required complementary units or services 3.3.3. Patient care pathways, protocols and clinical guidelines in the field of expertise 3.3.. External coordination, care management and follow-up of patients 3.3.5. Research, training, health technology assessment in the field of expertise 3.3.6. Specific information systems 3

3.3.7. Do you recommend any additional criteria or option that would effectively address the issue? 3.3.7.1. Space for further comments: additional criteria